According to the latest data from the Hong Kong Stock Exchange, on June 8th, Chairman and Chief Executive Officer Lou Jing increased his holdings in 3SBIO (HKEX: 01530) by 516,000 shares. The transaction price was HK$15.2497 per share, resulting in a total consideration of approximately HK$7.8688 million.
Following this acquisition, his total shareholding has risen to approximately 534 million shares, representing a 21.03% stake in the company. Additional information notes that Dr. Lou Jing is an enforcer and beneficiary of an unnamed discretionary trust.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments